ClickCease vs Free Ad Diagnosis Tool in 2026: Invalid-traffic protection vs first-pass campaign triage

ClickCease is for an advertiser that has evidence or a strong operational reason to address invalid paid traffic. It connects Google Ads, Meta Ads, and Microsoft Ads accounts, evaluates paid visits, and applies exclusions when a detection reaches its threshold. The exclusion route differs by platform: Google can receive IP and audience exclusions, while Meta and Microsoft use audience exclusions. That makes the product an intervention layer for traffic quality rather than a dashboard that merely labels unusual clicks after the fact.

The broader product matters when invalid visits are polluting more than media reports. Pixel Guard prevents Google tracking tags from firing for flagged sessions, so those sessions do not contribute events, audiences, or Smart Bidding signals. WordPress Bot Mitigation is presented as a WordPress product that routes identified malicious bots to a 403 page. Lead Shield works with HubSpot forms, writes a verdict and risk score into HubSpot, and allows the customer to block a flagged submission or pass it through with a flag. Teams outside WordPress and HubSpot should not count those two layers as general integrations.

Starter is advertised at $69 monthly for the first three billing cycles, then $99 monthly billed annually. Pro is $104 then $149, and Advanced is $244 then $349, all with a 7-day trial. Published plans include ad protection, Bot Mitigation, Lead Shield, Consent Mode compatibility, and Pixel Guard; Pro and Advanced add multiple domains, agency permissions, an account overview, and white-label reporting. Confirm capacity before purchase because the pricing page presents conflicting traffic, protected-domain, and HubSpot-lead allowances in different places.

Free Ad Diagnosis Tool is an intentionally lightweight starting point for an advertiser who knows a campaign has gone wrong but cannot yet name the likely failure stage. The browser-based journey begins with a concrete problem, such as poor lead quality, high CPL, a performance drop, high CPC, weak sales despite leads, or uncertainty. It then follows separate Google Ads and Meta Ads paths. The distinction is useful because search-intent fit and a post-click experience are not the same investigation as Meta creative, audience exposure, or lead capture.

The Google path can ask for campaign type, spend, clicks, leads, CPC, Quality Score, location targeting, tracking, search intent, and the next step after a click. The Meta path can ask for creative format, objective, audience, spend, impressions, reach, link clicks, leads, frequency, and capture method. For short video or Reels, it can use entered three-second views and ThruPlays to produce directional hook and hold signals. The result can show a health score, confidence figure, first focus, funnel stages, and up to four checks, but all of it depends on the quality of the answers entered.

It is free, does not require account access, and can print a result. A later diagnosis can be compared with the last browser result using local storage. There are no published paid tiers, API, integrations, team workspace, scheduled monitoring, or client-delivery features. Use it to make the first manual review less random, then verify the hypothesis in Google Ads, Meta Ads Manager, analytics, and the landing experience before changing spend, targeting, or creative.